Status:
TERMINATED
Evaluation of an Early Screening Test of Chronic Rejection and of Operational Tolerance by MicroArray in Renal Graft (Protocol DPRC Array)
Lead Sponsor:
Nantes University Hospital
Conditions:
First Cadaveric Renal Graft
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
The aim of the study is to explore the possibility to identify, at an early stage after a renal graft and from blood samples collected within first months after graft, a predictive transcriptional pro...
Eligibility Criteria
Inclusion
- Patients aged 18 to 65 years old,
- Donor's age ≤ 60 years old,
- Patients receiving a first cadaveric renal graft,
- Patients taking immunosuppressant treatment including an induction with Simulect at day 0 and day 4, FK 506 (Prograf®) associated with Cellcept and steroids (for three months),
- Patients don't taking indispensable anticoagulant treatment.
Exclusion
- Patient's age \< 18 or \> 65 years old,
- Donor's age ≥ 60 years old,
- Pregnant women or breast feeding women,
- Patients receiving a retransplantation, a kidney and pancreas graft or a graft from a living donor,
- Patients taking immunosuppressant treatment without FK 506 (Prograf®), Cellcept and steroids.
- Patients with coagulation troubles or taking indispensable anticoagulant treatment,
- No biopsy before graft.
Key Trial Info
Start Date :
May 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2011
Estimated Enrollment :
134 Patients enrolled
Trial Details
Trial ID
NCT00746057
Start Date
May 1 2006
End Date
May 1 2011
Last Update
September 30 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU de Nantes
Nantes, France